SCHEMBL32665130

SCHEMBL32665130

OC1CC(c2cccc(OCc3ccccc3)c2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.53
CYP4F2 P78329 1/20 0.51
CYP4A11 Q02928 1/20 0.51
KCNH2 Q12809 1/20 0.51
MAOB P27338 5/20 0.50
NR4A2 P43354 1/20 0.50
TNKS2 Q9H2K2 1/20 0.48
BCHE P06276 1/20 0.48
MAOA P21397 1/20 0.47
SMPD1 P17405 1/20 0.46
GRIN1 Q05586 4/20 0.46
GRIN2B Q13224 1/20 0.46
FAAH O00519 1/20 0.45
CNR2 P34972 1/20 0.45
ALOX5 P09917 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29666652 0.87 KCNH2 (0.53) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL6583019 0.84 MAOB (0.56) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL32665380 0.84 KDM1A (0.52) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL6583023 0.82 SPHK1 (0.58) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL6588487 0.82 SPHK1 (0.55) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL12354455 0.81 SPHK1 (0.60) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL28190298 0.81 TNKS2 (0.52) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL23364801 0.80 KCNH2 (0.49) KDM1ACYP4F2CYP4A11KCNH2MAOB
SCHEMBL9162340 0.80 ALOX5 (0.48) KDM1AKCNH2MAOBALOX5MEN1
SCHEMBL9162330 0.80 ALOX5 (0.48) KDM1AKCNH2MAOBALOX5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A KDM1A 4345/4885CYP4F2 2351/4885CYP4A11 4466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.